OPX Biotechnologies Lands $36,500,000 Series C Financing Round

  • Feed Type
  • Date
    7/7/2011
  • Company Name
    OPX Biotechnologies
  • Mailing Address
    2425 55th Street Boulder, CO 80301
  • Company Description
    OPX Biotechnologies, Inc. is a new company dedicated to enabling renewable fuels and chemicals that are economically and environmentally superior to petroleum-based products. We are using a pioneering technology platform known as SCALEs to enable massively parallel full genome search and modification to rapidly optimize the microbes used for producing biofuels and biorefined chemicals. Our goal is to vastly decrease production costs and capital requirements, thus removing one of the major barriers to the use of renewable fuels and chemicals.
  • Website
    http://www.opxbiotechnologies.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $36,500,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The new investment will enable OPXBIO to accelerate development and commercialization of an industrial-scale process for producing its first renewable chemical, BioAcrylic.
  • M&A Terms
  • Venture Investor
    US Renewables Group
  • Venture Investor
    DBL Investors
  • Venture Investor
    Mohr Davidow Ventures
  • Venture Investor
    Braemar Energy Ventures
  • Venture Investor
    Altira Group
  • Venture Investor
    X/Seed Capital